Back to results
US 12,006,546 B2Granted
Method for epigenetic immune cell detection and counting in human blood samples
AssigneePrecision for Medicine GmbH
InventorSven Olek
Life of this patent
Estimating the term…
Abstract
The present invention relates to improved methods for epigenetic blood and immune cell detection and counting, and respective uses and kits.
Claims17
A method for producing and detecting a panel of amplicons, the method comprising the steps of
- a) bisulfite treating isolated genomic DNA from a human blood cell sample containing immune cells to convert unmethylated cytosines into uracil;
- b) amplifying the bisulfite treated DNA to produce the panel of amplicons;
- wherein said amplifying comprises amplification and/or qPCR using:
- a thymidine-cytosine (TpG) template carrying targets of converted genomic regions of CD3gamma/delta, CD4, CD8beta, lipoprotein receptor-related protein 5 (LRP5), mevalonate pyrophosphate decarboxylase (MVD), and lipocalin-2 (LCN2), and
- primer pairs and probes for the converted genomic regions of CD3gamma/delta, CD4, CD8beta, LRP5, MVD, and LCN2, the primer pairs and probes selected from SEQ ID NOs:
- 3 to 12 for CD4, SEQ ID NOs:
- 13 to 20 for CD8beta, SEQ ID NOs:
- 21 to 28 for LRP5, SEQ ID NOs:
- 29 to 36 for MVD, SEQ ID NOs:
- 37 to 44 for LCN2, and SEQ ID NOs:
- 45 to 56 for CD3gamma/delta, and
- c) detecting the panel of amplicons.
9 more elements
Dependencies are inferred from the claim text.